-+ 0.00%
-+ 0.00%
-+ 0.00%

*Jasper Therapeutics: Combined Co Will Focus on Advancing Consolidated Pipeline of Potential Best-In-Class Innovative Therapies for Immunologically-Driven Disorders >JSPR

Dow Jones·07/16/2026 21:24:00

Please log in to view news